Abstract
Extramedullary plasmacytoma (EMP) of the vulva is an extremely rare clinical entity. This study presents the first documented case of EMP occurring in the left labia majora of a 36-year-old pregnant patient. Initially misdiagnosed as a common vulvar ulcer, the 7×4×2-cm mass was correctly identified through biopsy and immunohistochemistry. Following the termination of pregnancy, a combined-modality approach of targeted radiotherapy (4,500 cGy) and subsequent conservative surgery was employed. This strategy successfully eradicated the malignancy while preserving the anatomical appearance and psychosexual function of the vulva. At a 9-month follow-up, the patient remained disease-free with no progression to multiple myeloma.
Introduction
Extramedullary plasmacytoma (EMP) is a rare plasma cell dyscrasia characterized by the proliferation of monoclonal plasma cells in soft tissues outside the bone marrow. While approximately 80% of EMPs occur in the upper respiratory tract, they can manifest in nearly any organ. EMP of the vulva is exceptionally rare, and its occurrence during pregnancy presents unique diagnostic and therapeutic challenges. This case highlights the importance of biopsy in non-responsive vulvar lesions and the efficacy of function-preserving treatment protocols.
Case Presentation
A 36-year-old pregnant woman presented with a painful, ulcerated mass in the left labia majora measuring 7×4×2 cm. The lesion, which featured pus and blood scabs, had been previously misdiagnosed as a simple vulvar ulcer at a local clinic and failed to respond to antibiotic therapy. Magnetic resonance imaging (MRI) was utilized to define the extent of the tumor and rule out local lymphadenopathy.
Diagnosis
To confirm the diagnosis, a biopsy was performed. Histopathological and immunohistochemical (IHC) analysis revealed a dense infiltration of clonal plasma cells. The cells tested positive for CD79a and κ-light chain, confirming the diagnosis of EMP. A comprehensive systemic workup, including bone marrow aspiration and protein electrophoresis, excluded the coexistence of multiple myeloma (MM).
Treatment Strategy
The primary goal was to eradicate the tumor while synchronously preserving the patient's anatomical integrity and quality of life. Following the patient's decision to terminate the pregnancy, she received external beam radiotherapy with a total dose of 4,500 cGy. This neoadjuvant-like approach significantly reduced the tumor volume, shrinking the 7-cm mass to small residual nodules.
Forty days after the completion of radiotherapy—allowing for the resolution of acute radiation-induced edema—an extended local excision and reconstructive anaplasty were performed. This conservative surgical approach was made possible by the dramatic tumor response to radiation.
Results and Discussion
Post-operative pathological examination of the excised tissue showed no remaining viable tumor cells, confirming the efficacy of the combined treatment. The patient reported a satisfactory return to near-normal vulvar appearance and maintained a healthy sexual life, achieving the goal of function preservation.
While the patient remained disease-free at a 9-month follow-up, the authors emphasize that long-term surveillance is mandatory. EMP carries a significant risk (5–44%) of progressing to systemic multiple myeloma, sometimes occurring years after the initial presentation.
Conclusion
This case demonstrates that for EMP in anatomically sensitive areas, a sequential approach of radiotherapy followed by conservative surgery is highly effective. This strategy allows for complete oncological clearance while avoiding the physical and psychological morbidity associated with radical vulvectomy.
Summary updated